Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Journal of Cellular Biochemistry|December 17, 2011
CaM kinase control of AKT and LNCaP cell survivalJohn M Schmitt, Samantha Smith, Brendon Hart, et al.
Cancer Medicine|August 28, 2023
Real-world genomic testing and treatment patterns of newly diagnosed adult acute myeloid leukemia patients within a comprehensive health systemJohn C Byrd, Jennifer L Gatz, Cynthia Lim Louis, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
Intensive care unit admission from the emergency department in the setting of National Emergency Access TargetsJack D'Arcy, Suzanne Doherty, Luke Fletcher, et al.
Hematology/Oncology and Stem Cell Therapy|March 6, 2019
Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 yearsCurtis Lachowiez, Rachel J Cook, Brandon Hayes-Lattin, et al.
Annals of Hematology|February 2, 2023
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United StatesAmer M Zeidan, Daniel A Pollyea, Uma Borate, et al.
Journal of Business Ethics : JBE|June 26, 2023
Ethics and the Future of Meaningful Work: Introduction to the Special IssueEvgenia I Lysova, Jennifer Tosti-Kharas, Christopher Michaelson, et al.
Translational Behavioral Medicine|February 2, 2018
Improving shared decision-making in chronic lymphocytic leukemia through multidisciplinary educationGabrielle B Rocque, Courtney P Williams, Karina I Halilova, et al.
Breast Cancer Research : BCR|November 7, 2024
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancerJasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
The Oncologist|May 25, 2026
Add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: a randomized phase 3 studyJean-Jacques Kiladjian, Uma Borate, Elisabetta Abruzzese, et al.
Blood|December 9, 2024
Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromesJacqueline S Garcia, Uwe Platzbecker, Olatoyosi Odenike, et al.
Pageof 8